Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Partnerships + Prevention = Value-Driven Care — featuring Katie Adamson of YMCA

S1 Ep3: Partnerships + Prevention = Value-Driven Care — featuring Katie Adamson of YMCA of the USA

Vice President, Health Partnerships and Policy

Microsoft's Collaboration with Healthcare Leaders for Trustworthy AI

AI&#39;s potential to revolutionize healthcare requires a focus on responsible and trustworthy implementation. In this episode, Dr. David Rhew from Microsoft, along with Marcella Dalrymple and Dr. Michael Pencina from Duke Health, discuss the collaboration between Microsoft and Duke Health to explore the transformative potential of artificial intelligence (AI) in healthcare. Dr. Rhew emphasizes the importance of responsible and trustworthy AI, acknowledging its limitations and the need for operationalizing key principles. Dr. Pencina outlines four principles for trustworthy AI: prioritizing the human person, defining AI use cases, anticipating consequences, and establishing governance. Marcella Dalrymple, with her community perspective, highlights the necessity of addressing public uncertainty and mistrust regarding AI development. The partnership aims to form a Center of Excellence for trustworthy AI, focusing on collaborative efforts to align with ethical values and engage the community bidirectionally. The guests stress the importance of a robust governance system, automation for efficiency, and continuous monitoring to ensure AI&#39;s intended impact. Tune in and learn how this collaboration strives to revolutionize healthcare responsibly through AI! About David Rhew:Since August 2019, David has served as Chief Medical Officer &amp; VP of Healthcare for Microsoft&#39;s Worldwide Commercial Business (WCB). David and his team&#39;s main goal is to demonstrate how a large-scale data-driven approach can lead to smarter decision-making, more proactive care, and improved health outcomes, as well as lower costs for patients and populations. Additionally, David is an adjunct professor at the Department of Medicine, Division of Primary Care and Population Health at Stanford University. About Marcella Dalrymple:Marcella is the Associate Director of Strategic Development and Business Partnerships at Duke AI Health. Her goal is to operationalize novel ideas by using big data to achieve the most meaningful results, leading to improved clinical practices. Prior to that role, she was the Commercial Leadership Associate in the marketing sector for AstraZeneca and a project manager for Duke Clinical Research Institute. About Michael Pencina:Michael Pencina, PhD, is Duke Health&#39;s Chief Data Scientist and serves as Vice Dean for Data Science, Director of Duke AI Health, and Professor of Biostatistics and Bioinformatics at the Duke University School of Medicine. He develops and implements quantitative science strategies for the School of Medicine, co-chairs Duke Health’s Algorithm-Based Clinical Decision Support (ABCDS) Oversight Committee, and co-directs Duke’s Collaborative to Advance Clinical Health Equity (CACHE). Things You’ll Learn:<ul><li>AI&#39;s potential to revolutionize healthcare requires a focus on responsible and trustworthy implementation.</li><li>The collaboration between Microsoft and Duke Health aims to create a Center of Excellence for trustworthy AI.</li><li>The four principles for trustworthy AI are: prioritize the human person, define use cases, anticipate consequences, and establish governance.</li><li>Public mistrust of AI in healthcare highlights the need for community engagement and bidirectional communication.</li><li>Automation in governance processes can streamline AI integration and reduce friction in workflows.</li></ul>Resources:<ul><li>Connect with and follow David Rhew on <a href="https://www.linkedin.com/in/david-rhew-m-d-1832764/" target="_blank">LinkedIn</a>.</li><li>Follow Microsoft on <a href="https://www.linkedin.com/company/microsoft/" target="_blank">LinkedIn</a> and visit their <a href="https://news.microsoft.com/source/" target="_blank">website</a>.</li><li>Connect with and follow Marcella Dalrymple on <a href="https://www.linkedin.com/in/marcella-dalrymple-mphmba/" target="_blank">LinkedIn</a>.</li><li>Connect with and follow Michael Pencina on <a href="https://www.linkedin.com/in/michael-pencina-89194a42/" target="_blank">LinkedIn</a>.</li><li>Follow Duke Health AI on <a href="https://www.linkedin.com/company/duke-ai-health/" target="_blank">LinkedIn</a> and visit their <a href="https://aihealth.duke.edu/" target="_blank">website</a>.</li></ul>

S4 E32: Microsoft's Collaboration with Healthcare Leaders for Trustworthy AI

Global Chief Medical Officer, VP of Healthcare Worldwide Commercial

Chief Data Scientist for Duke Health; Vice Dean for Data Science; Director, Duke AI Health; Professor, Biostatistics & Bioinformatics; Duke University School of Medicine

Associate Director of Strategic Development and Business Partnerships

Why Women Distrust the Healthcare System—featuring Carolyn Witte

50% of women distrust the healthcare system in the US. Yet women make up 51% of the population and control 80% of the healthcare dollars. So, what does it look like to build trust with women in a healthcare setting? Carolyn Witte is Cofounder and CEO of Tia, the modern medical home for women. Carolyn’s team is dedicated to treating women holistically rather than by body part or life stage. Tia&#39;s Whole Woman, Whole Life care model fuses gynecology, primary care, mental health and evidence-based wellness services to treat women comprehensively. On this episode of HLTH Matters, Carolyn joins hosts Dr. Jessica Shepherd, Dr. Gautam Gulati and Dr. Jordan Shlain to discuss how Tia was created out of her frustration as a patient and describe the company’s evolution from the Google for women’s health to care delivery platform. Carolyn explains how point solutions exacerbate the fragmentation of healthcare for women and what Tia is doing to serve the whole woman, addressing her physical, mental and reproductive health. Listen in to understand how Tia builds trust by listening to what real women want and learn what Carolyn’s team does to make women feel seen, heard and cared for. Topics Covered<ul><li>How Tia was created out of Carolyn’s frustration as a patient</li><li>Tia’s evolution from the Google for women’s health to care delivery platform</li><li>Why 50% of women distrust the healthcare system and why it matters</li><li>Carolyn’s take on the politicization of women’s health</li><li>How point solutions exacerbate the fragmentation of healthcare for women</li><li>How Tia serves the whole woman within the framework of health insurance coding and reimbursements</li><li>The biggest users of virtual care (on Tia and among the general population)</li><li>How Tia is supporting women in a post-Dobbs world</li><li>The obstacles Tia faces in terms of reproductive health restrictions, regulations and investment in women’s health</li><li>What Tia does to make women feel seen, heard and cared for</li><li>Carolyn’s dream to give every woman access to Tia-style care</li><li>How Tia builds trust by listening to what real women want</li></ul>  Connect with Carolyn WitteTia Connect with Dr. Jessica Shepherd, Dr. Gautam Gulati &amp; Dr. Jordan ShlainHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInDr. Shlain on TwitterDr. Shlain on LinkedIn ResourcesDobbs v. Jackson Women’s Health OrganizationTim Urban’s Life Calendar

S3 Ep34: Why Women Distrust the Healthcare System—featuring Carolyn Witte

CEO and Co-Founder

The Beat: Sanofi's Pattern Recognition in Vaccine Development

The vaccine business is highly competitive. But Sanofi stands out particularly well. In this episode, Deborah Glasser, Sanofi’s Head of Vaccines for North America, delves into Sanofi&#39;s extensive history in the vaccine business, focusing on areas such as influenza, neurology, and rare diseases. Deborah provides a glimpse into the groundbreaking RSV monoclonal antibody, Beyfortus, designed to protect infants from the leading cause of hospitalizations. She emphasizes the unique approach of using a monoclonal antibody for newborns, highlighting its potential to revolutionize RSV prevention. Deborah also touches on Sanofi&#39;s efforts in flu prevention, such as consumer education and the importance of immunization, especially for the vulnerable population aged 65 and older. She sheds light on Sanofi&#39;s innovative use of Artificial Intelligence (AI) in both drug discovery and commercial practices and shares Sanofi&#39;s interest in collaborating with startups, particularly those aligned with health system goals. Tune in and learn how Sanofi&#39;s dedication to science and technology shapes the landscape of vaccine development and public health. About Deborah Glasser:Deborah Glasser holds an MBA in Marketing and Finance from the University of Chicago Booth School of Business and a B.A. with honors from Tufts University. Deborah is currently the Head of Vaccines in North America at Sanofi. In this role, she spearheads a team committed to pursuing scientific breakthroughs, focusing on the development and enhancement of immunizations. Sanofi, a global pharmaceutical giant, places a strong emphasis on innovation, and Deborah plays a crucial role in driving the vision forward, expanding access to vaccines, and advancing public health initiatives throughout the U.S. and Canada. Drawing on a rich and varied professional background, Deborah brings more than a decade of experience to her current role. Her journey includes an illustrious 13-year tenure at Biogen, where she held diverse positions across its U.S., European, and global organizations. Notably, she played a key role in the successful launch of Tecfidera, an oral multiple sclerosis product that achieved remarkable success, generating $1.3 billion in U.S. sales within its first four full quarters on the market. Things You’ll Learn:<ul><li>The vaccine industry faces intense competition.</li><li>RSV stands as the primary reason for infant hospitalizations.</li><li>Approximately 70 out of every 100,000 individuals end up hospitalized due to the flu.</li><li>The flu poses a significant and serious risk, with an average of 36,000 deaths annually, potentially reaching 98,000 in severe seasons. These deaths are preventable.</li><li>It&#39;s crucial to recognize the seriousness of the flu and take preventive measures to avoid unnecessary fatalities.</li></ul> Resources:<ul><li>Connect with and follow Deborah Glasser on <a href="https://www.linkedin.com/in/deborah-glasser-b06643/" target="_blank">LinkedIn</a>.</li><li>Follow Sanofi on <a href="https://www.linkedin.com/company/sanofi/" target="_blank">LinkedIn</a> and visit their <a href="https://www.sanofi.com/en" target="_blank">website</a>.</li></ul>

S1 E6: The Beat: Sanofi's Pattern Recognition in Vaccine Development

Head of Vaccines, North America

Podcast

S1 Ep3: Partnerships + Prevention = Value-Driven Care — featuring Katie Adamson of YMCA of the USA

FEATURING